Fish Oil for the Treatment of Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
Abstract
Omega-3 fatty acids, which are found abundantly in fish oil, are increasingly being used in the management of cardiovascular disease. It is clear that fish oil, in clinically used doses (typically 4 g/d of eicosapentaenoic acid and docosahexaenoic acid) reduce high triglycerides. However, the role of omega-3 fatty acids in reducing mortality, sudden death, arrhythmias, myocardial infarction, and heart failure has not yet been established. This review will focus on the current clinical uses of fish oil and provide an update on their effects on triglycerides, coronary artery disease, heart failure, and arrhythmia. We will explore the dietary sources of fish oil as compared with drug therapy, and discuss the use of fish oil products in combination with other commonly used lipid-lowering agents. We will examine the underlying mechanism of fish oil's action on triglyceride reduction, plaque stability, and effect in diabetes, and review the newly discovered anti-inflammatory effects of fish oil. Finally, we will examine the limitations of current data and suggest recommendations for fish oil use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another issue is poor product quality and purity, including contaminants, cholesterol, saturated fats, and oxidation products (Figs. 1, 2) [57, 59–66].”
From Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review (2020) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932 · cited 1×
“In recent years there has been a growing body of evidence that is shifting the paradigm of how inflammation is contained and dissipated.(4) In this new model, inflammation resolution is an active process mediated by lipid-derived compounds.”
Backgroundde Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · cited 5×
“For patients without documented CAD, the American Heart Association 2006 Diet and Lifestyle Recommendations advise the consumption of at least 2 servings of fish per week, preferably fatty fish high in DHA and EPA.65 The guidelines also recommend a daily fish intake equivalent to 1 g/d of EPA and DHA for secondary pre…”
MethodInfluentialYokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
de Lorgeril, M., Renaud, S., Salen, P., Monjaud, I., Mamelle, N., Martin, J. L., Guidollet, J., Touboul, P., & Delaye, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92580-1 · Cited by 2,122 · cited 1×
“The Lyon Diet Heart Study, performed shortly after the DART study, was a prospective trial of 607 survivors of MI who were randomized to either a Mediterranean diet or a regular Western diet.(49) At a mean follow-up of 27 months, the primary end point of death from cardiovascular causes and nonfatal deaths had a 73% r…”
Method
Research works printed but not linked: 1
- Jacobsen, 1997, Ins-(1,4.5)-P and arrhythmogenic responses during myocardial reperfusion., Am J Physiol, 273, H1119
Cited by
Microencapsulation of oils: A comprehensive review of benefits, techniques, and applications
Bakry, A. M., Abbas, S., Ali, B., Majeed, H., Abouelwafa, M. Y., Mousa, A., & Liang, L. (2016) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12179 · Cited by 918
Sokoła-Wysoczańska, E., Wysoczański, T., Wagner, J., Czyż, K., Bodkowski, R., Lochyński, S., & Patkowska-Sokoła, B. (2018) · Nutrients · doi:10.3390/nu10101561 · Cited by 360
“The fish oil and mustard oil groups showed a significant reduction in total cardiac arrhythmias, left ventricular enlargement, and angina pectoris compared to the placebo group [106].”
BackgroundMarine Omega-3 Phospholipids: Metabolism and Biological Activities
Burri, L., Hoem, N., Banni, S., & Berge, K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131115401 · Cited by 257
Omega-3 fatty acid supplementation and cardiovascular disease
Jump, D. B., Depner, C. M., & Tripathy, S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r027904 · Cited by 239
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
Backes, J., Anzalone, D., Hilleman, D., & Catini, J. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0286-4 · Cited by 195
“OM3FA dietary supplements are also available, but as these products do not need to comply with the rigorous regulations required for prescription formulations, and do not require approval from the FDA, their OM3FA content is often inconsistent and may be inadequate to effectively treat hypertriglyceridemia [25–27].”
Background
Metadata
- Authors
- Weitz, D., Weintraub, H., Fisher, E., & Schwartzbard, A. Z.
- Affiliations
- NYU Langone Health (US)
- Corresponding author
- Weitz, Daniel
- Venue
- Cardiology in Review
- Published
- 2010-09
- Volume
- 18
- Issue
- 5
- Pages
- 258-263
- ISSN
- 1061-5377 (ISSN-L)
- PMC
- PMC3217043
- OpenAlex
- W2036364822
- Cited by
- 138
- References
- 88
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 4 · 2018: 9 · 2017: 12 · 2016: 8 · 2015: 14 · 2014: 11 · 2013: 16 · 2012: 10
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cardiology in Review (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01 HL58541, R01HL058541)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- fish oil, omega-3 fatty acids, cardiovascular disease, triglyceride lowering, coronary artery disease, heart failure, cardiac arrhythmias, sudden cardiac death, myocardial infarction, plaque stability, diabetes mellitus, anti-inflammatory activity, lipid-lowering drugs, eicosapentaenoic acid, docosahexaenoic acid
- MeSH terms
- Hypolipidemic Agents, Arrhythmias, Cardiac, Cardiovascular Diseases, Diabetes Mellitus, Fish Oils, Heart Failure, Humans, Fenofibrate, Triglycerides, United States, Fatty Acids, Omega-3, Death, Sudden, Cardiac, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fish Oil for the Treatment of Cardiovascular Disease. https://app.cochat.ai/papers/10.1097/crd.0b013e3181ea0de0
- The paper
- Weitz, D., Weintraub, H., Fisher, E., & Schwartzbard, A. Z. (2010). Fish Oil for the Treatment of Cardiovascular Disease. Cardiology in Review. https://doi.org/10.1097/crd.0b013e3181ea0de0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.